Validation of spectrophometric methods for quantitative determination the lisiniy substance

Abstract

Cardio-vascular diseases it is a main cause reason of death in all world: cause of this reason most of all people die. How show statistic WHO every year perish 17,5 million people, it’s 31% percent by all population/ 85% percent have stroke or heart attack. People with poor financial level suffer especially, cause they didn’t have heath services, also no services than can diagnose primary symptoms. So most of our population die in young age. How show statistic many family spent a lot of money for therapy, cause pills cost expensive. We have a forecast which present that somewhere about 23,6 million people die by reason of stroke or heart attack. Main fact that 80% percent of this heart diseases can avoided if you as don’t smoke, eat heathy food, do exercise’s, don’t use alcohol, all this items concern for all people. If people have CVD and minor diseases they first need in early diagnosis and in treatment. We have pills which can decrease effect of metabolic reaction, who provoke ischemia, and they united by name “metabolite tropic cardio protectors”. The main attention attracts the publication about medicines based by thiazol, especially original medicines and his analog. That’s why we have a plot made a medicines which have cationic-anionic action development of pharmaceutical chemistry at by created SPA new substance, which have named “Liziniy” which also have cardio protection neuro protection function on endothelium of vascular. So how you can observe plot of our method it is created new modern methods of substance standardization “Liziniy” and definition of validation characteristics of our methods.